相关实验视频

Updated: Jun 21, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

鉴定用于Mycobacterium结核病药物开发的新ClpC1-NTD结合剂

Katharina Weinhäupl¹, Louis Meuret², Sandy Desrat²

¹Institute for Research and Innovation in HealthI3S, Porto, Portugal. kathi.weinhaeupl@gmail.com.

Scientific reports

|February 3, 2025

概括

研究人员发现了针对MtbClpC1蛋白质的新化合物,这是结核病的关键参与者. 这些新型候选药物与天然抗生素结合到相同的部位,为结核病治疗提供了新的途径.

科学领域:

药物的发现和开发.
微生物学微生物学
结构生物学是结构生物学.

背景情况:

结核病 (TB) 仍然是一个重大的全球卫生挑战,需要新的治疗策略.
MtbClpC1蛋白是有效的抗结核药物标.
针对MtbClpC1的天然产品抗生素显示出希望,但在临床使用方面存在局限性.

研究的目的:

为了识别抑制MtbClpC1功能的新型小分子.
探索针对结核病的替代治疗剂.
在MtbClpC1 N-终端域上验证新的绑定站点.

主要方法:

针对MtbClpC1 N-终端域的小型化合物库的in silico选.
化合物结合和功能抑制的实验验证.
在MtbClpC1 N端域内结合相互作用的表征.

主要成果:

识别了具有微分子亲和力的新型MtbClpC1 N-终端域结合剂.
实验证实,已识别的化合物与天然产品抗生素结合到相同的口袋.
新发现的化合物对MtbClpC1功能抑制的证明.

结论:

在子查是有效的发现新的MtbClpC1抑制剂.
这些已识别的化合物代表了开发新抗结核病药物的有希望的线索.
针对MtbClpC1 N-终端域为结核病药物开发提供了一个可行的策略.

关键词:

陪伴者是指一个陪伴者.这就是ClpC1的意思.在状的中.主人公 Protags 在结核病是一种疾病.

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

相关概念视频

Rapid Identification of Pathogens

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...